EGLN3 and nonpapillary renal cell carcinoma: Consequently, the expression of CA9, NDUFA4L2, EGLN3, BHLHE41, VWF, IGFBP3, and ANGPTL4 is associated with ccRCC tumor progression and decreases at stage 4 after initial growth relative to normal tissues.